Simple physician-prompting intervention drastically improves outcomes in CHD


Creighton University, Omaha, NE-Despite the evidence that lipid-lowering drug therapy-especially with HMG-CoA reductase inhibitors (statins)-is known to save lives and help prevent subsequent events in coronary heart disease (CHD) patients, utilization of this class of drugs is erratic.

Related Content
© 2023 MJH Life Sciences

All rights reserved.